In a rapidly evolving landscape, advocacy for longevity has become increasingly crucial as advancements in scientific understanding do not always align with policy changes. In our final expert roundup for 2025, we engage with six prominent figures in longevity advocacy to reflect on the year’s successes, failures, and realizations as we look toward 2026.

Successes and Failures in Longevity Advocacy

Andrew Steele, Author and Longevity Scientist

Andrew Steele notes a dual trend in 2025 where the visibility of the term 'longevity' has increased, mirroring a growing public awareness. However, he expresses concern that much of this attention revolves around traditional lifestyle advice—adequate sleep, exercise, and popular diets—rather than advanced medical interventions necessary to decelerate biological aging.

Melissa King and Bernard Siegel, Co-founders of HSAC

According to King and Siegel, 2025 represented a significant transformation as longevity shifted from being a niche scientific interest to a broader policy consideration. They highlight the introduction of various initiatives like Montana's expansion of the "Right to Try" laws, as well as the proposal of the THRIVE Act, aimed at creating regulatory pathways for healthspan-extending therapies. They remain optimistic yet cautious about a perceived funding crisis and the need to maintain public trust amid commercialization hurdles.

Dylan Livingston, Founder of A4LI

Dylan Livingston perceives 2025 as a pivotal year, particularly with Jim O’Neill's appointment to a senior role in the HHS. He acknowledges the challenges of unrealistic expectations within the industry but maintains an optimistic long-term outlook as structural barriers to innovation appear to loosen.

Adam Gries, Co-founder of the Vitalism Society

Gries emphasizes that the legislative measures in states like New Hampshire and Florida are indicative of a shift towards recognizing and implementing innovative health solutions. His assertiveness in advocacy remains steadfast, pointing to the potential of increasing coordination among diverse stakeholders.

Anastasia Egorova, CEO of Open Longevity

Egorova highlights the mixed reception of advocacy efforts in 2025. Although public figures like Bryan Johnson gained notoriety, she questions the tangible benefits of such fame on substantive research. She regards the year as laying groundwork for future advancements, even if results have not yet achieved widespread recognition.

Influential Events of 2025

Shifting gears, the experts discussed pivotal events from 2025 that may shape the future of longevity advocacy:

  • Andrew Steele: The exchange between Xi Jinping and Vladimir Putin talking about organ transplantation grabbed global media attention, which fed into negative perceptions of longevity science.
  • Melissa King and Bernard Siegel: The shifts in public policy, such as Right-to-Try expansions, marked a significant transition into public governance discussions regarding longevity initiatives.
  • Dylan Livingston: A4LI's Montana Right-to-Try bill gained considerable media attention, demonstrating that longevity is gradually gaining serious discourse in mainstream outlets.
  • Adam Gries: The appointment of key longevity advocates to leadership positions made headlines and signaled a more aggressive push for aging-related therapies.
  • Anastasia Egorova: The political climate was affected greatly by global tensions, overshadowing the nuanced discussions often required in the field of longevity.

Reflections on Surprises and Updated Perspectives

Reflecting on their expectations from the beginning of 2025, the advocates expounded upon how the year's events shifted their outlooks:

Andrew Steele

Steele was surprised by the public's engagement with longevity concepts, noting even his dentist was aware of relevant documentaries, indicating a growing cultural footprint.

Melissa King and Bernard Siegel

The rapid policy progress at the state and federal levels caught them off guard, defying their initial belief that scientific validation would precede such changes.

Dylan Livingston

Livingston did not experience many surprises, viewing the year as a natural progression in an evolving field he has closely monitored.

Adam Gries

Gries was particularly struck by the variety and speed of state-level regulations and how they could foster the delivery of longevity therapies.

Anastasia Egorova

Egorova chose to refrain from detailed commentary on this question, reflecting an ongoing contemplation about the trajectory of longevity advocacy.

Forward-Looking Insights for 2026

As the experts turned their eyes to 2026, they shared their hopes and concerns:

Andrew Steele

Steele plans to revitalize the narrative around longevity science through initiatives aimed at public engagement and policy advocacy across Europe and the UK.

Melissa King and Bernard Siegel

They foresee promoting healthspan as a fundamental human right and hope to catalyze strong dialogue around regulatory and legislative frameworks that could bolster public health.

Dylan Livingston

Livingston anticipates continuity in progress but warns that effective communication strategies will be essential to counter misinformation as conversations around longevity escalate.

Adam Gries

Gries emphasizes the importance of attracting talented individuals into governmental roles to drive lasting change in longevity-related fields.

Anastasia Egorova

Egorova reflects on the challenge of relevance, acknowledging that the field remains on the fringe of mainstream discussion, but encouraging bold initiatives from within the community.

Conclusion

The evolving dynamics of longevity advocacy paint a picture of both opportunities for progress and potential pitfalls to navigate. Each advocate presents valuable perspectives on engagement, public perception, and the need for continued vigilance in fostering a robust future for longevity initiatives. By harnessing passion and collaboration, there remains hope for transforming this field into a fundamental component of public health discourse.

About the Author

Arkadi Mazin is a seasoned journalist and op-ed author with a passion for learning and exploration. His interests span from politics to science and philosophy. Having studied economics and international relations, he is particularly interested in the social aspects of longevity and life extension. He strongly believes that life extension is an achievable and noble goal that has yet to take its rightful place on the very top of our civilization’s agenda – a situation he is eager to change.

Support Independent Journalism

We would like to ask you for a small favor. We are a non-profit foundation with no shareholders or products to sell. All our news and educational content is free for everyone to read, but we rely on contributions from supporters like you. Every donation, no matter the size, helps sustain independent journalism and supports our mission.

Subscription

Sign up to stay informed about the latest news and opportunities with the Lifespan Research Institute!